Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is a dual GLP-1 and GIP receptor agonist , meaning it acts on two hormones instead of one
Tirzepatide Powder stands as the world's first dual-agonist API, simultaneously targeting both GIP and GLP-1 receptors to deliver unprecedented therapeutic outcomes in metabolic disorder management
While you dont need to make any strict dietary changes while taking semaglutide, most people will find that they will naturally want to consume fewer calories
Saniona has been developing Tesomet for hypothalamic obesity and Prader-Willi syndrome
US$ 29.34
US$ 23.50
US$ 25.07
US$ 24.04
